Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Use of Various Types of Introducers in Conventional Radial Access (TIRE)

8 mei 2026 bijgewerkt door: Aleksandr V. Bocharov, PhD, MD, Pirogov Russian National Research Medical University

The purpose of this intervention study is to compare different types of radial introducers used in traditional radial access in terms of the incidence of complications.

The main questions it aims to answer are:

  1. Does a smaller outer diameter of the introducer reduce the risk of complications associated with radial access?
  2. Does the presence of an outer hydrophilic coating on the introducer reduce the risk of complications associated with radial access?
  3. Does the use of an introducer with a smaller outer diameter and an outer hydrophilic coating reduce the risk of complications associated with radial access? The researchers will compare the number of complications associated with radial access when using conventional diameter, uncoated radial introducers, conventional diameter introducers with an outer hydrophilic coating, or reduced outer diameter introducers with an outer hydrophilic coating.

During the scheduled revascularization procedure, the participants will undergo radial artery catheterization using one of the types of introducers. Complications from the radiation access will be recorded by doctors within 72 hours after the intervention.

Studie Overzicht

Gedetailleerde beschrijving

Objective: to compare different types of radial introducers used in conventional radial access by the frequency of complications.

Scientific hypotheses:

  1. The risk of acute radial artery occlusion depends on the outer diameter of the introducer.
  2. The risk of acute radial artery occlusion depends on the presence of an outer hydrophilic coating on the introducer.
  3. The risk of persistent radial artery spasm depends on the presence of an outer hydrophilic coating on the introducer.
  4. The risk of persistent radial artery spasm depends on the outer diameter of the introducer.

Patients were enrolled by endovascular specialists with experience of at least 250 radial-access procedures per year.

Inclusion criteria: clear pulsation of the right radial artery, indications for percutaneous coronary intervention.

Exclusion criteria: previous unsuccessful radial artery catheterization; concomitant pathology limiting patient survival; disorders of the blood coagulation system (hemophilia, thrombocytopathy, etc.); previous coronary artery bypass grafting; occlusion of the right radial artery.

The required sample size was calculated using the method of M. Bland for a high-precision study. The required significance level (α) was 0.001 and the statistical power was 95%. The expected rate of radial artery occlusion in the Rad, Rad polymer, and Rad slender groups was assumed to be 12%, 8%, and 8%, respectively. Under these conditions, the calculated sample size was 2723 patients. The planned loss during the study was 20%. Thus, the minimum sample size was 3268 patients.

The study had an experimental design and complied with the CONSORT protocol. A simple randomization method using a random-number generator was chosen. The type of randomization was permuted block randomization. The total block size was 3000, and the allocation ratio between the groups was 1:1:0.7.

Puncture of the right radial artery was performed after local anesthesia with a 2% lidocaine solution. The radial artery was punctured at the typical site using the puncture needle included in the introducer set, with only the anterior wall being punctured. The type of introducer was selected by randomization using a random-number method, and depending on this assignment the patient was allocated to one of the groups.

All patients underwent percutaneous coronary angioplasty with coronary artery stenting via the right radial artery. The radial artery catheterization technique did not differ between groups. The type of introducer was selected by randomization using a random-number method, and depending on this assignment the patient was allocated to one of the groups. In the Rad group , introducers without a hydrophilic coating were used; in the Rad polymer group , introducers with a hydrophilic coating were used; and in the Rad slender group , thin-walled introducers with a hydrophilic coating were used. The access site was examined within 3 hours after the intervention and then, in the absence of complaints, again at bandage removal. After bandage removal, patients underwent ultrasound examination to confirm radial artery patency. Complications from the radiation access will be recorded by doctors within 72 hours after the intervention.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

3307

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

    • Kostroma Oblast
      • Kostroma, Kostroma Oblast, Rusland, 156013
        • E.I. Korolev Kostroma Regional Clinical Hospital
    • Moscow
      • Moscow, Moscow, Rusland, 119071
        • Central Clinical Hospital of St. Alexy Metropolitan of Moscow of the Moscow Patriarchate of the Russian Orthodox Church

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • clear pulsation of the right radial artery
  • indications for percutaneous coronary intervention

Exclusion Criteria:

  • previous unsuccessful radial artery catheterization
  • concomitant pathology limiting patient survival
  • disorders of the blood coagulation system (hemophilia, thrombocytopathy, etc.)
  • previous coronary artery bypass grafting
  • occlusion of the right radial artery

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Dubbele

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Rad classic
Introducer with a standard outer diameter and no external hydrophilic coating

The right radial artery was punctured under local anesthesia with a 2% lidocaine solution. The radial artery was punctured at a typical location using a puncture needle included in the catheterization kit, puncturing only the anterior wall.

An introducer with a standard outer diameter and no external hydrophilic coating was inserted.

5,000 IU of heparin in saline solution was injected into the catheterized artery. All injected solutions, including radiocontrast agents, had a temperature of 36.5-36.7 °C. Hemostasis was achieved by applying a pressure bandage.

The access site was examined 3 hours after the intervention, and then, if there were no complaints, it was examined again when the bandage was removed. After the bandage was removed, patients underwent an ultrasound examination to confirm the patency of the radial artery.

Complications were recorded within 3 days after the intervention.

Experimenteel: Rad polymer
Introducer with a standard outer diameter and an outer hydrophilic coating

Description: The right radial artery was punctured under local anesthesia with a 2% lidocaine solution. The radial artery was punctured at a typical location using a puncture needle included in the catheterization kit, puncturing only the anterior wall.

An introducer with a standard outer diameter and an outer hydrophilic coating was using.

5,000 IU of heparin in saline solution was injected into the catheterized artery. All injected solutions, including radiocontrast agents, had a temperature of 36.5-36.7 °C. Hemostasis was achieved by applying a pressure bandage. The access site was examined 3 hours after the intervention, and then, if there were no complaints, it was examined again when the bandage was removed. After the bandage was removed, patients underwent an ultrasound examination to confirm the patency of the radial artery. Complications were recorded within 3 days after the intervention.

Experimenteel: Rad slender
Introducer with a reduced outer diameter and an outer hydrophilic coating

Description: The right radial artery was punctured under local anesthesia with a 2% lidocaine solution. The radial artery was punctured at a typical location using a puncture needle included in the catheterization kit, puncturing only the anterior wall.

An introducer with a reduced outer diameter and an outer hydrophilic coating was using.

5,000 IU of heparin in saline solution was injected into the catheterized artery. All injected solutions, including radiocontrast agents, had a temperature of 36.5-36.7 °C. Hemostasis was achieved by applying a pressure bandage. The access site was examined 3 hours after the intervention, and then, if there were no complaints, it was examined again when the bandage was removed. After the bandage was removed, patients underwent an ultrasound examination to confirm the patency of the radial artery. Complications were recorded within 3 days after the intervention.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Acute radial artery occlusion after catheterization
Tijdsspanne: Within 72 hours after radial artery catheterization
Acute radial artery occlusion was confirmed by ultrasound examination
Within 72 hours after radial artery catheterization
Radial artery perforation
Tijdsspanne: Perioperative/Periprocedural
Angiography-confirmed perforation of the radial artery
Perioperative/Periprocedural
Radial artery false aneurysm
Tijdsspanne: Within 72 hours after radial artery catheterization
A false aneurysm of the radial artery was confirmed by ultrasound examination
Within 72 hours after radial artery catheterization
Hematoma by classification EASY Grade II
Tijdsspanne: Within 72 hours after radial artery catheterization
Hematoma by classification EASY Grade II was confirmed by ultrasound examination
Within 72 hours after radial artery catheterization
Persistent radial artery spasm
Tijdsspanne: Perioperative/Periprocedural
Persistent radial artery spasm confirmed by angiography
Perioperative/Periprocedural

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

28 januari 2019

Primaire voltooiing (Werkelijk)

16 december 2025

Studie voltooiing (Werkelijk)

19 december 2025

Studieregistratiedata

Eerst ingediend

22 april 2026

Eerst ingediend dat voldeed aan de QC-criteria

6 mei 2026

Eerst geplaatst (Werkelijk)

7 mei 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

13 mei 2026

Laatste update ingediend die voldeed aan QC-criteria

8 mei 2026

Laatst geverifieerd

1 mei 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

Beschrijving IPD-plan

all personal data underlying the publication results

IPD-tijdsbestek voor delen

Beginning 6 months and ending 1 years after the publication of results

IPD delen Ondersteunend informatietype

  • LEERPROTOCOOL
  • SAP
  • MVO

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren